SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-12-035415
Filing Date
2012-06-19
Accepted
2012-06-19 16:21:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 v316356_s3.htm S-3 299107
2 EXHIBIT 4.2 v316356_ex4-2.htm EX-4.2 300814
3 EXHIBIT 5.1 v316356_ex5-1.htm EX-5.1 23834
4 EXHIBIT 12.1 v316356_ex12-1.htm EX-12.1 18082
5 EXHIBIT 23.1 v316356_ex23-1.htm EX-23.1 2967
  Complete submission text file 0001144204-12-035415.txt   645815
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-182216 | Film No.: 12915253
SIC: 2836 Biological Products, (No Diagnostic Substances)